1Holmes DR Jr,Leon MB,Moses Jw,et al.Analysis of 1-year clinical outcomes in the SIRIUS trial:a randomized trial of a sirolimus-eluting stent versus a standard stent in patients[J].Circulation,2004,109:634-640.
2Berger PB,Sketch MH,Califf RM,et al.Choosing between percutaneous coronary intervention and coronary artery by pass grafting for patients with multivessel disease:What can we learn for the Arterial revascularization therapy study(ARTS)[J]?Circulation,2004,109:1079-1081.
4Joner M,Finn AV,et al.Pathology of drug-eluting stents in humans:delayed healing and late thrombotic risk[J].J Am Coll Cardial,2006,48:193-202.
5Doucet S,Schalij MJ,Vrolix MC,et al.Stent Placement to prevent restenosis after angioplasty in small coronary arteries[J].Ciculation,2001,104:2029-2033.
6Hwang CW,Levin AD,Jonas M,et al.Thrombosis modulates arterial drug distribution for drug-eluting stents[J].Circulation,2005,111:1619-1626.
7Takebayashi H,Mintz GS,Carlier SG,et al.Nonuniformstrut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation[J].Circulation,2004,110:3430-3434.
9Nebeker JR,Virmani R,Bennett CL,et al.Hypersensitivity cases associated with drug-eluting coronary stents:a review of available cases from the Research on Adverse Drug Events and Reports (RADAR)project[J].J Am Coll Cardiol,2006,47:175.
